Cargando…
Unilateral facial injection of Botulinum neurotoxin A attenuates bilateral trigeminal neuropathic pain and anxiety-like behaviors through inhibition of TLR2-mediated neuroinflammation in mice
OBJECTIVES: In this study, we investigated the possible analgesic effects of Botulinum toxin type A (BoNT/A) on trigeminal neuralgia (TN). A modified TN mouse model was established by chronic constriction injury of the distal infraorbital nerve (dIoN-CCI) in mice, and the possible roles of microglia...
Autores principales: | Chen, Wei-Jia, Niu, Jing-Qi, Chen, Yi-Ting, Deng, Wen-Jing, Xu, Ying-Ying, Liu, Jing, Luo, Wei-Feng, Liu, Tong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Milan
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8130347/ https://www.ncbi.nlm.nih.gov/pubmed/34000998 http://dx.doi.org/10.1186/s10194-021-01254-2 |
Ejemplares similares
-
Botulinum Neurotoxin for the Treatment of Neuropathic Pain
por: Egeo, Gabriella, et al.
Publicado: (2020) -
TLR8 in the Trigeminal Ganglion Contributes to the Maintenance of Trigeminal Neuropathic Pain in Mice
por: Zhao, Lin-Xia, et al.
Publicado: (2020) -
Antinociceptive Effects of Transcytosed Botulinum Neurotoxin Type A on Trigeminal Nociception in Rats
por: Kim, Hye-Jin, et al.
Publicado: (2015) -
Botulinum neurotoxin type A for the treatment of pain: not just in migraine and trigeminal neuralgia
por: Sandrini, Giorgio, et al.
Publicado: (2017) -
Efficacy and Safety of Botulinum Toxin Type A in Treating Patients of Advanced Age with Idiopathic Trigeminal Neuralgia
por: Liu, Jing, et al.
Publicado: (2018)